14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Monday, 6th May 2024 ZNTL stock ended at $11.72. This is 0.0854% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.63% from a day low at $11.55 to a day high of $12.20.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Zentalis Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Feb 23, 2024 $14.02 $14.63 $13.50 $13.64 1 070 213
Feb 22, 2024 $13.60 $14.05 $13.42 $13.95 511 659
Feb 21, 2024 $13.67 $14.11 $13.43 $13.66 1 005 356
Feb 20, 2024 $12.97 $14.60 $12.97 $13.82 1 386 256
Feb 16, 2024 $12.38 $13.07 $12.26 $12.97 449 964
Feb 15, 2024 $12.16 $12.95 $12.08 $12.61 984 219
Feb 14, 2024 $11.06 $11.98 $10.85 $11.95 624 911
Feb 13, 2024 $10.96 $11.13 $10.57 $10.83 1 003 411
Feb 12, 2024 $11.43 $11.72 $11.29 $11.50 627 145
Feb 09, 2024 $11.71 $11.79 $11.27 $11.50 500 184
Feb 08, 2024 $11.35 $11.85 $11.14 $11.54 676 557
Feb 07, 2024 $11.55 $11.61 $10.90 $11.30 664 084
Feb 06, 2024 $11.22 $11.60 $10.87 $11.57 854 198
Feb 05, 2024 $11.34 $11.52 $11.09 $11.36 509 594
Feb 02, 2024 $11.44 $11.69 $10.93 $11.59 1 190 606
Feb 01, 2024 $11.92 $12.15 $11.64 $11.69 496 889
Jan 31, 2024 $12.09 $12.38 $11.79 $11.85 739 688
Jan 30, 2024 $13.03 $13.03 $12.08 $12.10 475 803
Jan 29, 2024 $12.69 $13.20 $12.20 $13.16 809 838
Jan 26, 2024 $13.25 $13.53 $12.60 $12.68 473 743
Jan 25, 2024 $13.23 $13.25 $12.63 $13.07 749 469
Jan 24, 2024 $13.65 $14.23 $13.02 $13.16 492 068
Jan 23, 2024 $14.07 $14.26 $13.02 $13.62 475 735
Jan 22, 2024 $12.96 $13.85 $12.87 $13.80 698 771
Jan 19, 2024 $12.99 $13.02 $12.56 $12.89 379 004
Click to get the best stock tips daily for free!

About Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid tumors; Phase 1/2 clinical trial for the treatment of advanced solid tumors as a monotherapy and in an ... ZNTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT